InterComponentWare AG (ICW) is a leading supplier of software for the healthcare IT market. ICW develops solutions for IT-based collaboration among healthcare professionals and their patients. ICW is your trusted partner for solutions that involve patients in their treatment plans and that securely exchange data across enterprises. ICW's clients operate successfully in many international markets and benefit from its expertise in implementing innovative trends and addressing current and future challenges in healthcare.
The internationally experienced team of around 60 employees successfully develops eHealth solutions for secure cross-enterprise information exchange in healthcare. Based on almost 20 years of experience, ICW eHealth Suite - powerful, connected Modules that form tailor-made solutions for the valued customers and partners - has been created.
The overall objective of this study was to propose recommendations for improving the current level of information provision to patients by National Contact Points (NCPs). The research methodology used in this study consisted of: literature review, analysis of legal texts, website analysis, pseudo-patient investigation, NCP and patient surveys, bilateral exchanges and a workshop with NCPs. Core findings of the study are: 
The AAL Market and Investment Report was commissioned by the Ambient Assisted Living Association and aims to provide a consolidated view of the existing market and investment information in Europe for the AAL domain. It covers data relevant for AAL and related technologies including current status, trends and future perspective for opportunities in the European Union (EU) and where possible link those to innovation in delivery of services.
The present report provides an analysis of the results of consultation activities carried out by the European Commission in preparation of a Communication on the Transformation of Health and Care in the Digital Single Market. The main findings show that over 93% of over 1400 respondents to an online questionnaire believe that "Citizens should be able to manage their own health data". Furthermore, 83% of all respondents either agree or strongly agree with the statement that "Sharing of health data could be beneficial to improve treatment, diagnosis and prevention of diseases across the EU". The overwhelming majority of all respondents (73.6%) identify improved possibilities for medical research as a reason for supporting cross border transfer of medical data, which was higher than for their purpose of their own treatment (67.8%). 
The healthcare industries cluster - HealthCapital Berlin-Brandenburg celebrates its 10 years anniversary. However, the tradition of the joint work of the States of Berlin and Brandenburg in the field of biotechnology and medical technology already goes back more than 20 years. During this time, the German capital region developed into one of the most dynamic metropolitan areas in Europe that stands for cosmopolitanism, innovation, creativity, and start-ups.
eHealth has quickly become a symbol of the democratization of healthcare, as well as an opportunity to meet the challenges caused by an ageing society, the epidemic of non-communicable and chronic diseases and the dramatically rising costs of healthcare. Some say that technology in the XXI century is a paradigm shift, which is unprecedented in history and because of that we cannot see clearly what lays ahead: is it 3D printing of human organs, decreasing the transaction costs in health or providing universal high-quality service to everyone at a fraction cost of the price we pay today. 
Immunisation information systems (IIS) are defined as confidential, population-based, computerised databases that record all immunisation doses administered by participating providers to persons residing within a given geopolitical area. At the point of clinical care, they support practitioner decision-making in ensuring appropriate individual vaccination and adherence to applicable policies. At population level, IIS provide aggregate data on vaccinations for use in surveillance and programme operations, and in guiding public health action to improve vaccination rates and reduce vaccine-preventable diseases.